GTBP·36254L209·UQ·equity·Healthcare - Biotechnology-13D/G
GTBP (GT Biopharma, Inc.) is held by 20 institutional investors as of Q4 2025. Largest holders: CITADEL ADVISORS LLC ($63,414), JANE STREET GROUP, LLC ($20,427), Integrated Wealth Concepts LLC ($15,709). Net institutional sentiment: Mixed.
See how GTBP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer